Food and Beverage
Food and drink products subject to safety, labeling, additive, contaminant, and contact material regulations across jurisdictions.
Foresight tracks Food and Beverage developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Not ready for a trial? Take the 3-minute readiness assessment
Current activity
Intensifying
60% above the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
13 May 2026, 12:32
Latest Food and Beverage alerts
The most recent regulatory and guidance signals tracked by Foresight
EFSA Updates Safety Evaluation for Food Enzyme Subtilisin (Bacillus licheniformis NZYM‑CX)
In May 2026 EFSA’s Panel on Food Enzymes concluded that extending the intended uses of the food enzyme subtilisin (Bacillus licheniformis NZYM‑CX) from eight to eleven food manufacturing processes, including cheese, distilled alcohol and plant extracts, does not raise safety concerns at the estimated dietary exposures. This positive risk assessment strengthens the case for broader EU authorisation of this enzyme and signals that food and beverage manufacturers may gain additional processing flexibility once the European Commission updates the Union list of permitted food enzymes.
EU EFSA Confirms Safety of Extended Use of Glucan 1,4‑α‑Glucosidase Food Enzyme (Aspergillus niger NZYM‑BF) in Baked Products
EFSA’s food enzyme panel has updated its safety assessment of glucan 1,4-α-glucosidase from genetically modified Aspergillus niger NZYM-BF, confirming that extending its use to baked products alongside brewed products and glucose syrups does not raise safety concerns. This opinion supports continued and potentially expanded use of the enzyme by EU food and ingredient manufacturers under existing food enzyme legislation without triggering new risk management constraints.
EFSA Concludes No Safety Concerns for Endo-1,4-β-Xylanase Food Enzyme From GM Bacillus licheniformis NZYM-FX
In April 2026 EFSA issued a scientific opinion concluding that the food enzyme endo-1,4-β-xylanase from genetically modified Bacillus licheniformis NZYM-FX does not raise safety concerns for its intended use in starch/gluten and distilled alcohol production, with negligible residual enzyme in final foods. This de-risks EU authorisation decisions for this enzyme and signals to food and enzyme manufacturers that, if approved, it is unlikely to impose additional safety-driven constraints beyond existing food hygiene and good manufacturing practices.
EFSA NDA Panel Concludes Safety of Schizochytrium sp. A2 Oil for Infant and Follow-On Formula Cannot Be Established
EFSA's NDA Panel has concluded that, on the current evidence, the safety of a DHA-rich oil from Schizochytrium sp. A2 proposed as a novel food ingredient for infant and follow-on formula and adult supplements cannot be established under the EU Novel Food framework. This means no immediate expansion of DHA sourcing options for EU infant formula and supplements, so manufacturers should continue relying on existing authorised ingredients while monitoring for any revised dossiers or Commission decisions.
EFSA Assesses Safety of Food Enzyme Aspergillopepsin I and Carboxypeptidase C from Aspergillus sp. ACP 112–311
EFSA has evaluated a food enzyme preparation containing aspergillopepsin I and carboxypeptidase C produced with non-genetically modified Aspergillus sp. strain ACP 112–311 and concluded it does not raise safety concerns at the proposed use levels across 13 food manufacturing processes, based on negative genotoxicity, a 90-day NOAEL of 180 mg TOS/kg bw per day, and a margin of exposure above 2,000. This opinion supports forthcoming EU authorisation decisions under the food enzyme framework and signals a low-risk profile for food and beverage manufacturers using this enzyme in dairy, baked goods, plant-based products, protein hydrolysates, beverages, and yeast-derived ingredients.
EFSA NDA Issues Opinion on Safety of Beta-Nicotinamide Mononucleotide (β-NMN) as a Novel Food for Adult Food Supplements
In May 2026 EFSA's NDA Panel concluded that chemically synthesised beta-nicotinamide mononucleotide (β-NMN) is safe as a novel food ingredient in adult food supplements at doses up to 300 mg per day, providing a bioavailable source of niacin under the EU novel foods and food supplements frameworks. This scientific opinion sets a clear safety benchmark for forthcoming EU authorisation decisions and gives supplement manufacturers an evidence-based intake limit and specification profile for any β-NMN products targeting the European market.
New Jersey Senate Bill S4230 Would Permanently Exempt Certain Polystyrene Foam Food Service Products
New Jersey has posted an early synopsis for Senate Bill S4230 for the 2026–2027 session indicating an intent to permanently exempt certain polystyrene foam food service products from the State’s existing prohibition on selling or providing such items. If this bill progresses and is enacted, it would narrow New Jersey’s polystyrene food service packaging ban and could ease compliance constraints and reopen packaging options for affected food service businesses and suppliers.
New Jersey Assembly Bill A5084 Would Require Labelling of Cell‑Cultivated Food
New Jersey lawmakers have filed Assembly Bill A5084 for the 2026–2027 session to require that foods containing animal cell-cultivated ingredients carry a clear label or indication of that content. If this proposal advances, food manufacturers and retailers selling into New Jersey may need to add state-specific "cell-cultivated" disclosures on packaging, menus, and point-of-sale materials to remain compliant with emerging labelling rules.
Greece EFET Recalls “Koulouria” Bakery Product Over Undeclared Hazelnut Allergen
EFET has ordered the recall of a “Koulouria” bakery product batch in Greece after official controls found undeclared hazelnut allergen in the product in May 2026. Food businesses and retailers should verify stocks, remove the affected lot, and strengthen allergen labelling and control systems to avoid similar enforcement actions and protect allergic consumers.
Greece Reports March 2026 Pesticide-Residue Monitoring Results For Plant-Based Foods
In May 2026 Greece reported that 97.7% of 311 plant-based food samples tested for pesticide residues in March 2026 complied with EU maximum residue limits, with seven non-compliant cases identified. These results confirm generally high compliance but highlight targeted enforcement against specific products and banned active substances, reinforcing the need for continued monitoring and supply-chain controls rather than signalling any immediate change in legal requirements.
Ukraine: Order No. 203 Tightens Dietary Supplement Composition and Health-Claim Rules (In Force 17 April 2026)
In April 2026 Ukraine’s Ministry of Health brought into force Order No. 203, tightening the compositional, labelling and health-claim rules for dietary supplements and for the addition of vitamins, minerals and certain other substances to foods. Manufacturers and importers of supplements and fortified foods now face clear upper limits for key nutrients, new bans and restrictions on certain ingredients and stricter marketing constraints, requiring prompt reviews of product formulas, labelling and claims for all products placed on the Ukrainian market.
US FDA Finalizes Enhanced Systematic Process for Post-Market Assessment of Chemicals in Food
In May 2026 the US FDA finalised an enhanced systematic process and prioritisation tool for post‑market assessment of chemicals in the food supply. This creates a more predictable, transparent framework for reviewing additives, contaminants and other food chemicals, signalling increased future scrutiny and potential regulatory action that food, ingredient and packaging suppliers must plan for.
EU Commission Renews Authorisation for GM Cotton T304-40 Under Regulation 1829/2003
In March 2026 the European Commission renewed, for a further ten years, the EU authorisation to place on the market food, feed and other products containing or produced from genetically modified cotton T304-40 under the GM food and feed framework. This maintains existing GM cotton T304-40 supply chains into the EU but keeps strict traceability, labelling (including “not for cultivation”) and environmental monitoring obligations in place for agri-food and feed businesses using these products.
California Updates WIC Food Benefits and Authorized Food List
California public health authorities have implemented USDA’s 2024 WIC food package revisions by updating the state’s WIC food benefits and authorised food list, expanding eligible whole grains, dairy alternatives, canned fish and fresh herbs for participants from May 2026. For retailers authorised to accept WIC in California, this locks in a refreshed 2026 authorised product set and POS rules, requiring inventories, coding and customer guidance to stay aligned with the new CDPH WIC food list and shopping guide.
Czech Republic (SZPI) Updates Interim Results of Infant Milk Formula Inspections — Status as of 11 May 2026
In May 2026, Czech regulator SZPI updated interim results from an inspection campaign on dried infant formulas containing arachidonic acid (ARA), testing products for cereulide toxin and Bacillus cereus. All sampled batches currently comply, but the targeted surveillance underscores ongoing scrutiny of microbiological risks in ARA-enriched infant nutrition placed on the Czech market.
EU Council Agrees Negotiating Position on Organic Farming Regulation
In May 2026, EU agriculture ministers agreed a Council negotiating position to amend the Organic Production Regulation, aiming to simplify organic rules, clarify import and labelling requirements, and extend time-limited flexibilities for some non-organic inputs. Organic producers, importers and retailers should expect upcoming changes to certification thresholds, use of the EU organic logo on imports, protein feed derogations and transition arrangements ahead of the 31 December 2026 expiry of current third-country equivalence agreements.
EU/EFSA Reopens Consultation On Post-Market Monitoring For GM Soybean MON 87769
EFSA has amended its scientific opinion on the renewal authorisation of GM soybean MON 87769 under EU GM food and feed law, and the European Commission has reopened a targeted public consultation on the updated post-market monitoring section until 11 June 2026. Food and feed operators using this GM soybean should monitor the consultation outcome because any refinements to the post-market monitoring plan could adjust ongoing reporting and surveillance expectations, even though EFSA’s overall safety conclusion remains unchanged.
Germany Issues Recall Of Globus Beeren-Mix (300 g) Due To Hepatitis A
Germany has issued an official recall warning for a specific batch of Globus frozen berry mix (300 g) after Hepatitis A virus was detected in product samples, affecting Globus stores across multiple federal states. This targeted food-safety enforcement action requires retailers and consumers to remove the affected batch from circulation immediately and underlines the need for close monitoring of microbiological risks in frozen fruit supply chains.
European Commission Clarifies Equivalence And Labelling For Category 1 NGT Plants
In May 2026 the European Commission answered an MEP question by confirming the scientific basis and regulatory safeguards for treating certain “category 1” plants obtained by new genomic techniques as equivalent to conventional plants under the draft NGT regulation. For companies in seeds, crops, and food and feed, this clarifies that these NGT varieties would be exempt from additional GMO risk assessment but remain subject to conventional‑plant rules, a monitoring programme, and public register and seed‑labelling transparency, informing how they design future breeding and segregation strategies.
EU Commission Describes RASFF Actions on Oestradiol in Brazilian Beef (E-000726/2026)
In May 2026 the European Commission explained how a November 2025 RASFF notification over oestradiol‑17β residues in Brazilian beef led to EU import consignments being blocked and withdrawn and to Brazilian farms being suspended from exporting female bovine meat to the EU. This episode signals strict enforcement of existing EU hormone-residue and official-control rules, meaning importers and Brazilian meat exporters should expect tight scrutiny, rapid market withdrawals, and ongoing audits where non-compliance is detected.
Not a newsletter. Not a feed.
Structured intelligence mapped to your business.
These are just a few of the most recent Food and Beverage alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Start free trialFrequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at